Revvity Inc.
Revvity, Inc. provides health sciences solutions, technologies, and services. The company offers instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services; and instruments, reagents, assay platforms and software products for early detection of common and rare conditions, such as pregnancy and early childhood, as well as infectio… Read more
Market Cap & Net Worth: Revvity Inc. (RVTY)
Revvity Inc. (NYSE:RVTY) has a market capitalization of $9.77 Billion ($9.77 Billion) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1819 globally and #1327 in its home market, demonstrating a -5.15% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Revvity Inc.'s stock price $87.37 by its total outstanding shares 111799374 (111.80 Million).
Revvity Inc. Market Cap History: 2015 to 2026
Revvity Inc.'s market capitalization history from 2015 to 2026. Data shows growth from $5.82 Billion to $9.77 Billion (6.02% CAGR).
Index Memberships
Revvity Inc. is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$53.17 Trillion | 0.03% | #454 of 503 |
Weight: Revvity Inc.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Revvity Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Revvity Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.79x
Revvity Inc.'s market cap is 3.79 times its annual revenue
0.69x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
44.76x
Revvity Inc.'s market cap is 44.76 times its annual earnings
363.13x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $5.70 Billion | $2.12 Billion | $233.68 Million | 2.69x | 24.39x |
| 2017 | $8.03 Billion | $2.26 Billion | $113.02 Million | 3.56x | 71.04x |
| 2018 | $8.66 Billion | $2.78 Billion | $238.79 Million | 3.12x | 36.25x |
| 2019 | $10.73 Billion | $2.88 Billion | $227.56 Million | 3.72x | 47.17x |
| 2020 | $15.91 Billion | $3.78 Billion | $728.10 Million | 4.20x | 21.85x |
| 2021 | $22.33 Billion | $3.83 Billion | $943.16 Million | 5.83x | 23.67x |
| 2022 | $15.60 Billion | $3.31 Billion | $569.18 Million | 4.71x | 27.41x |
| 2023 | $12.19 Billion | $2.75 Billion | -$118.38 Million | 4.43x | N/A |
| 2024 | $12.48 Billion | $2.76 Billion | $295.83 Million | 4.53x | 42.18x |
| 2025 | $10.82 Billion | $2.86 Billion | $241.68 Million | 3.79x | 44.76x |
Competitor Companies of RVTY by Market Capitalization
Companies near Revvity Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Revvity Inc. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Revvity Inc. Historical Marketcap From 2015 to 2026
Between 2015 and today, Revvity Inc.'s market cap moved from $5.82 Billion to $ 9.77 Billion, with a yearly change of 6.02%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $9.77 Billion | -9.70% |
| 2025 | $10.82 Billion | -13.31% |
| 2024 | $12.48 Billion | +2.37% |
| 2023 | $12.19 Billion | -21.87% |
| 2022 | $15.60 Billion | -30.13% |
| 2021 | $22.33 Billion | +40.37% |
| 2020 | $15.91 Billion | +48.20% |
| 2019 | $10.73 Billion | +24.01% |
| 2018 | $8.66 Billion | +7.80% |
| 2017 | $8.03 Billion | +40.85% |
| 2016 | $5.70 Billion | -2.12% |
| 2015 | $5.82 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Revvity Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.77 Billion USD |
| MoneyControl | $9.77 Billion USD |
| MarketWatch | $9.77 Billion USD |
| marketcap.company | $9.77 Billion USD |
| Reuters | $9.77 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.